Literature DB >> 20065141

Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis.

Mary Kurian1, Patrice H Lalive, Josep O Dalmau, Judit Horvath.   

Abstract

BACKGROUND: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis has been recently reported as autoimmune/paraneoplastic encephalitis, affecting mostly young females.
OBJECTIVE: To describe opsoclonus-myoclonus syndrome in association with anti-NMDAR antibodies.
DESIGN: Case report.
SETTING: Geneva University Hospital. Patient A 23-year-old woman with opsoclonus-myoclonus syndrome.
RESULTS: Two weeks after an episode of gastroenteritis, the patient developed symptoms of depression associated with psychomotor slowing, progressive gait instability, and opsoclonus-myoclonus. Cerebrospinal fluid examination showed mild lymphocytic pleocytosis and intrathecal IgG synthesis with oligoclonal bands. The patient's condition worsened rapidly to an akinetic mutism, followed by a period of agitation, delirium, and hallucinations. These gradually subsided; however, a frontal behavior and executive dysfunction persisted 5 months after symptom presentation. No tumor was found. Anti-NMDAR antibodies were found in the cerebrospinal fluid.
CONCLUSIONS: Opsoclonus-myoclonus may occur in patients with anti-NMDAR encephalitis. Prompt diagnosis of this disorder is important because after tumor removal and immunomodulatory therapies it has a relatively good prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065141      PMCID: PMC2819405          DOI: 10.1001/archneurol.2009.299

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Anti-N-methyl-D-aspartate receptor-related grave but reversible encephalitis with ovarian teratoma in 2 Japanese women presenting with excellent recovery without tumor resection.

Authors:  Akihiro Shindo; Ken Kagawa; Yuichiro Ii; Ryogen Sasaki; Yasumasa Kokubo; Shigeki Kuzuhara
Journal:  Eur Neurol       Date:  2008-11-25       Impact factor: 1.710

2.  Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.

Authors:  Ioannis Markakis; Eleni Alexiou; Michael Xifaras; Georgios Gekas; Antonios Rombos
Journal:  Clin Neurol Neurosurg       Date:  2008-04-22       Impact factor: 1.876

3.  Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma.

Authors:  A S Fitzpatrick; O M Gray; J McConville; G V McDonnell
Journal:  Neurology       Date:  2008-04-08       Impact factor: 9.910

4.  Autoantigen diversity in the opsoclonus-myoclonus syndrome.

Authors:  Luis Bataller; Myrna R Rosenfeld; Francesc Graus; Juan J Vilchez; Nai-Kong V Cheung; Josep Dalmau
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

5.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

6.  Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

Authors:  Nicole R Florance; Rebecca L Davis; Christopher Lam; Christina Szperka; Lei Zhou; Saba Ahmad; Cynthia J Campen; Heather Moss; Nadja Peter; Amy J Gleichman; Carol A Glaser; David R Lynch; Myrna R Rosenfeld; Josep Dalmau
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

  6 in total
  6 in total

1.  Paraneoplastic disorders of eye movements.

Authors:  Shirley H Wray; Josep Dalmau; Athena Chen; Susan King; R John Leigh
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

2.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

3.  Anti-N-methyl-D-aspartate receptor encephalitis with minimal cortical impairment.

Authors:  Erdem Tüzün; Recai Türkoğlu; Sami M Yumerhodzha; Ece Erdağ; Mefkure Eraksoy; Gülşen Akman-Demir
Journal:  Neurol Sci       Date:  2012-01-10       Impact factor: 3.307

Review 4.  Paraneoplastic neurological syndromes.

Authors:  F Leypoldt; K-P Wandinger
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 5.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

Review 6.  Myoclonus: Pathophysiology and Treatment Options.

Authors:  Ariel Levy; Robert Chen
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.972

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.